Johnson & Johnson (JNJ) trades at $227.20 after rising $1.80 (0.78%) over the past week, positioning the price in the upper part of the weekly range. The asset sits ...
Johnson & Johnson (JNJ) is currently trading at $225.78, down $5.18 or 2.24% for the day. The asset remains below its 20-day ($227.79) and 50-day ($232.77) moving averages, but stays well above ...
Johnson & Johnson (JNJ) is currently trading at $230.62, sitting below the weekly MA-20 ($234.17) but well above both the MA-50 ($204.01) and MA-200 ($170.52). Over the ...
Johnson & Johnson (JNJ) shares are trading at $227.69, which is below the weekly MA-20 ($232.56) but well above the MA-50 ($202.42) and MA-200 ($170.21). Over the last ...
Johnson & Johnson (JNJ) is currently trading at $229.57, up 2.19% on the day. The stock is positioned above its 20-day moving average, below its 50-day, and well above its 200-day, suggesting ...
The House Committee on Energy and Commerce is set to convene one subcommittee hearing and two subcommittee markups in Washington this week. The agenda spans power transmission permitting, public ...
Johnson & Johnson (JNJ) is currently trading at $228.12, which is below the weekly MA-20 ($231.35), but well above both the MA-50 ($200.89) and MA-200 ($169.92). Over ...
Johnson & Johnson (JNJ) is currently trading at $224.73, having declined by $2.56 (0.98%) over the last week and closing near the bottom of its recent weekly range. The ...
A bipartisan group of U.S. senators is pressing the State Department to release already appropriated funds for Gavi, the global vaccine alliance. The lawmakers say $600 million approved for fiscal ...
Florida healthcare providers are urging policymakers to expand access to preventive care as chronic disease continues to strain patients and public health finances. A House Ways and Means Health ...
Johnson & Johnson (JNJ) is currently trading at $225.43, posting a weekly decline of $2.15 or 1.00%. The asset sits just below its W1 MA-20 ($229.79), while holding well ...
Johnson & Johnson (JNJ) is currently trading at $226.06, having declined by $8.24, or 3.53%, over the past week. The asset sits just below its weekly MA-20 ($229.15), ...
Competition for investment and recruiting talent remains a central operational issue for large hedge funds, particularly as firms expand specialist hiring teams. Citadel's chief people officer ...
Johnson & Johnson (JNJ) is currently trading at $240.15, rising $1.79 (0.75%) over the past week and maintaining a position well above its weekly MA-20 ($227.89), MA-50 ...
Johnson & Johnson (JNJ) is trading slightly below the MA-20 at $241.67, but remains above the MA-50 at $235.37 and well above the MA-200 at $195.40. The current price of $240.67 marks a daily gain ...
Johnson & Johnson (JNJ) is trading near $235.37, and the retracement has been gradual but persistent throughout most of March. What matters now is the post-spinoff earnings profile. TTM EPS is ...
Johnson & Johnson (JNJ) is trading at $238.23 after a daily drop of 2.04%. The price is below the SMA-20 of $244.18, but above the SMA-50 at $231.66 and well above the SMA-200 at ...
Johnson & Johnson (JNJ) ended the week at $238.84, recording a weekly decline of $9.63 or 3.88%. Despite this drop, the asset remains well above its weekly MA-20 ...
Johnson & Johnson (JNJ) shares have fallen to $237.17, trading below the MA-20 ($243.29) but remaining well above the MA-50 ($226.07) and MA-200 ($189.36). This setup indicates short-term downside ...
Johnson & Johnson (JNJ) is trading at $237.65, having declined 3.15% today. The price is below the MA-20 ($243.29), highlighting near-term selling pressure, though it ...
Johnson & Johnson (JNJ) is trading at $248.66, posting a daily gain of $5.19 or 2.13%. The price stands well above the MA-20 at $239.74, MA-50 at $223.13, and MA-200 at $187.40, confirming a solid ...